D-0023-2026 Class III Ongoing

Recalled by STAQ Pharma, Inc. — Denver, CO

FDA drug recall D-0023-2026 was initiated by STAQ Pharma, Inc. on Oct 9, 2025 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Oct 22, 2025
Initiation Date
Oct 9, 2025
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Distribution pattern

Nationwide in the U.S.

Code information

Lot #: 25104595A, Expiry: 27DEC2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0023-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0023-2026. Report a data issue: hello@regdatalab.com.